Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Overview of attention for article published in The Lancet, May 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#15 of 41,134)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 433 news outlets
blogs: 32 blogs
policy: 5 policy sources
twitter: 13145 tweeters
patent: 5 patents
peer_reviews: 1 peer review site

facebook: 25 Facebook pages
wikipedia: 18 Wikipedia pages
reddit: 7 Redditors
f1000: 1 research highlight platform
video: 9 video uploaders

Citations

dimensions_citation: 2757 Dimensions

Readers on

mendeley: 3370 Mendeley

Summary News Blogs Policy documents Twitter Patents Peer reviews Facebook Wikipedia Reddit Research highlights Video Dimensions citations

So far, Dimensions has found 2,757 publications that cite this research output.

2,757

The most recent citing publications are shown below. View all 2,757 publications that cite this research output on Dimensions.

Recent progress of molecular diagnosis via CRISPR Cas-based biosensors and bioassays

Article in Talanta Open (August 2023)

Translatability scoring in prospective and retrospective COVID drug development cases.

Article in European Journal of Clinical Pharmacology (June 2023)

Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC

Article in Frontiers in Endocrinology (June 2023)